Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Baxter Pharmaceuticals India Pvt Ltd
FDA Inspection
•Baxter Pharmaceuticals India Pvt Ltd•January 27, 2023

Baxter Pharmaceuticals India Pvt Ltd – FDA Inspection, Jan 27, 2023

Record Details

This FDA Inspection record concerns Baxter Pharmaceuticals India Pvt Ltd, with an inspection on January 27, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Baxter Pharmaceuticals India Pvt Ltd
Inspection Date
January 27, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Justin A. Boyd (Investigator)
  • Pratik S. Upadhyay (FDA Associated Person)
View Company Profile

ID · fc31be04-c1f8-435e-bce6-5fb197082a57

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1195842
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

18
  1. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  2. 21 CFR 211.63Equipment Design, Size and Location
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.113(b)Procedures for sterile drug products
  5. 21 CFR 211.186(a)Written procedures followed
  6. 21 CFR 211.188(b)(5)In-Process and Laboratory Control Results
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.67(b)Written procedures not established/followed
  9. 21 CFR 211.100(a)Absence of Written Procedures
  10. 21 CFR 211.100(a)Absence of Written Procedures

Showing 10 of 18 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Baxter Pharmaceuticals India Pvt Ltd

10
DateClassificationOfficeProject area
June 27, 2025Not classifiedOffice of Inspections and Investigations
May 17, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 4, 2017OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 31, 2017Not classifiedOffice of Inspections and Investigations
August 26, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for Baxter Pharmaceuticals India Pvt Ltd
  • FDA Inspection 1280282 - 2025-06-27
  • FDA Inspection 1169631 - 2022-05-17
  • FDA Inspection 1028732 - 2017-08-04
  • FDA Inspection 1019107 - 2017-05-31
  • FDA Inspection 986348 - 2016-08-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Baxter Pharmaceuticals India Pvt Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.